Embolotherapy Market Size to Reach USD 7.13 Billion in 2028 Growing at a CAGR of 9.3%, according to Emergen Research

Emergen Research has published its latest report titled “Embolotherapy Market, By Product Type (Embolic Agents, Embolization Coils, Detachable Balloons, Embolic Plug Systems, Support Devices, and Others), By Procedure (Transcatheter Arterial Embolization, Transcatheter Arterial Radioembolization, Transcatheter Chemoembolization), By Application (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological & Nephrological Disorders, Others), By End-use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), and By Region, Forecast to 2028”

According to Emergen Research, the global embolotherapy market size was USD 3.50 Billion in 2020 and is expected to reach USD 7.13 Billion in 2028 and register a revenue CAGR of 9.3% during the forecast period, 2021-2028.

Market Dynamics:

The global embolotherapy market revenue growth is majorly attributed to factors such as increasing prevalence of chronic and acute diseases across the globe, rise in global geriatric population, increasing occurrences of lifestyle-related disorders, and growing demand for minimally invasive surgical procedures. Embolotherapy is an endovascular treatment method that involves occlusion of abnormal blood vessels to control bleeding, prevent arteriovenous malformations and tumor growth, and enable devascularization of organs. It is a minimally invasive technique that utilizes several embolic agents such as angiographic catheters, gel foam, coils, and balloons to make occlusions.

Increasing implementation of the embolization therapy in treatment of cancer, endovascular disease, and traumatic injuries, and rising cases of aneurysms, cerebrovascular malformation, venous malformation, arteriovenous malformation, and pediatric vascular conditions are other key factors expected to drive the global embolotherapy market revenue growth over the upcoming years. Technological advances in embolotherapy devices such as detachable and pushable coils, resorbable particles, drug-elutable microspheres, and high-flow microcatheter technology are further expected to bolster market revenue growth.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/763

COVID-19 Impact Analysis:

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants  continue to cause concerns and impact normal routines

Embolic Agents Segment Accounted for Largest Revenue Share in 2020:

The embolic agents segment, which is sub-segmented into liquid embolic agents and microspheres, accounted for the largest revenue share in the global market in 2020. Growing prevalence of hepatocellular carcinoma, growing use of liquid embolic agents to prevent arteriovenous malformation, increasing use of embolic microspheres in embolization of arteriovenous malformations, hypervascular tumors, symptomatic uterine fibroids, and prostate arteries, and rising R&D activities to develop more advanced embolic agents drive the growth of this segment.

Cancer Application Segment to Account for Fastest Revenue CAGR:

Based on application, the global embolotherapy market is segmented into cancer, peripheral vascular disease, neurological disease, urological & nephrological disorders, and others. The cancer segment is projected to register the fastest revenue CAGR over the forecast period. Factors supporting the growth of this segment are increasing prevalence of cancer globally, including blood, liver, and kidney cancers, rising volumes of chemoembolization procedures to treat liver cancer, and growing use of embolotherapy in combination with radiation therapy and chemotherapy.

North America Accounted for Largest Revenue Share in 2020:

Among regional markets, the North America embolotherapy market dominated other regions in terms of revenue share in the global market in 2020. Increasing geriatric population, rising prevalence of cancer, growing use of embolization techniques in interventional radiology procedures, and presence of state-of-the-art healthcare infrastructure and highly skilled surgeons and radiologists are key factors bolstering the regional market revenue growth. Increasing number of ambulatory surgical centers, growing preference for transcatheter embolization devices, and rising healthcare expenditures of people further boost the revenue growth.  

Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/763

Major Companies in the Global Embolotherapy Market Include:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Medical Corporation
  • Penumbra Inc.
  • Johnson & Johnson
  • Merit Medical Systems Inc.
  • Cook Medical Inc.
  • Kaneka Corporation
  • Stryker Corporation

For the purpose of this report, Emergen Research has segmented the global embolotherapy market based on product type, procedure, application, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2018–2028)

  • Embolic Agents
  • Liquid Embolic Agents
  • Microspheres
  • Embolization Coils
  • Detachable Coils
  • Pushable Coils
  • Detachable Balloons
  • Embolic Plug Systems
  • Support Devices
  • Microcatheters
  • Guidewires

Procedure Outlook (Revenue, USD Billion; 2018–2028)

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization
  • Transcatheter Chemoembolization

Application Outlook (Revenue, USD Billion; 2018–2028)

  • Cancer
  • Peripheral Vascular Disease
  • Neurological Disease
  • Urological & Nephrological Disorders
  • Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/embolotherapy-market

Region Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of Middle East & Africa

Explore Reports offered by Emergen Research:

The global clinical perinatal software market size was valued at USD 212.6 Million in 2019 and is forecasted to reach USD 393.3 Million by 2027 at a CAGR of 7.9%. The clinical perinatal software market is observing high demand attributed to its increasing application in workflow management, fetal monitor data services, and patient documentation.

The Global GERD Drugs and Devices Market size was valued at USD 5.10 Billion in 2019 and is anticipated to reach USD 6.14 Billion by 2027 at a CAGR of 2.3%. The market is driven by the rise in the awareness level about GERD and the growing trend for self-medication.

The Global Oncology Informatics Market size was valued at USD 4.62 Billion in 2019 and is anticipated to reach USD 8.01 Billion by 2027 at a CAGR of 7.1%. An increase in the awareness of the different types of treatment options for oncology will drive the demand for the oncology informatics market.

The global MRI systems market size was valued at USD 6,097.8 Million in 2019 and is forecasted to reach USD 8,249.3 Million by 2027 at a CAGR of 3.8%. The magnetic resonance imaging systems market is observing high demand attributed to its rising usage in neurological, musculoskeletal, vascular, spine, cardiac, abdominal, and breast cancer.

The global immunotherapy drugs market size was USD 154.40 Billion in 2019 and is expected to reach USD 365.57 Billion by 2027, at a CAGR of 12.1% during the forecast period. The global immunotherapy drugs market is anticipated to expand substantially in the near future, owing to the increasing cancer incidence across the globe.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Full Press Release@ https://www.emergenresearch.com/press-release/global-embolotherapy-market

Back to news